×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [2]
Faculty of Healt... [2]
THE STATE KEY LA... [1]
Authors
WANG CHUNMING [1]
BIAN YING [1]
HOU JIAJIE [1]
Document Type
Journal article [3]
Date Issued
2024 [1]
2023 [1]
2018 [1]
Language
英語English [2]
Source Publication
ACTA PHARMACOLOG... [1]
BIOMATERIALS [1]
Medicine [1]
Indexed By
SCIE [3]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-3 of 3
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Journal Impact Factor Ascending
Journal Impact Factor Descending
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
E3 ubiquitin ligase UBR5 modulates circadian rhythm by facilitating the ubiquitination and degradation of the key clock transcription factor BMAL1
Journal article
Duan, Chunyan, Li, Yue, Zhi, Haoyu, Tian, Yao, Huang, Zhengyun, Chen, Suping, Zhang, Yang, Liu, Qing, Zhou, Liang, Jiang, Xiaogang, Ullah, Kifayat, Guo, Qing, Liu, Zhaohui, Xu, Ying, Han, Junhai, Hou, Jiajie, O’Connor, Darran P., Xu, Guo qiang. E3 ubiquitin ligase UBR5 modulates circadian rhythm by facilitating the ubiquitination and degradation of the key clock transcription factor BMAL1[J]. ACTA PHARMACOLOGICA SINICA, 2024, 45(9), 1793-1808.
Authors:
Duan, Chunyan
;
Li, Yue
;
Zhi, Haoyu
;
Tian, Yao
;
Huang, Zhengyun
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
1
IF:
6.9
/
7.6
|
Submit date:2024/06/05
Bmal1
Circadian Rhythm
Proteomics
Transcriptional Activity
Ubiquitination
Ubr5
Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis
Journal article
Ge, Pu, Han, Chunyan, Reyila, Abudurousuli, Liu, Diyue, Hong, Wenying, Liu, Jiaxin, Zhang, Jinzi, Han, Xiao, Li, Xialei, Huang, Mengjie, Fan, Siyuan, Kaierdebieke, Ayidana, Wu, Xiaoyu, Huang, Xiaolu, Guo, Weirui, Liu, Siyu, Bian, Ying. Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis[J]. Medicine, 2023, 102(35), e34793.
Authors:
Ge, Pu
;
Han, Chunyan
;
Reyila, Abudurousuli
;
Liu, Diyue
;
Hong, Wenying
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
1.3
/
1.6
|
Submit date:2023/09/12
Adverse Events
Aflibercept
Antiangiogenesis
Meta-analysis
Metastatic Colorectal Cancer
Safety
Systematic Review
Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors
Journal article
Gan, Jingjing, Dou, Yunyan, Li, Yurong, Wang, Zhenzhen, Wang, Lintao, Liu, Shang, Li, Qiu, Yu, Heran, Liu, Chunyan, Han, Congwei, Huang, Zhen, Zhang, Junfeng, Wang, Chunming, Dong, Lei. Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors[J]. BIOMATERIALS, 2018, 178, 95-108.
Authors:
Gan, Jingjing
;
Dou, Yunyan
;
Li, Yurong
;
Wang, Zhenzhen
;
Wang, Lintao
; et al.
Favorite
|
TC[WOS]:
93
TC[Scopus]:
97
IF:
12.8
/
13.1
|
Submit date:2018/10/30
Macrophage
Inflammatory Bowel Disease
Nanoparticle
Receptor Clustering